Over the past couple of years, the healthcare industry has seen significant growth in the adoption and use of electronic prescribing (e-prescribing) for controlled substances.

Accounting for 12 percent of all prescriptions annually, controlled substances such as opioid narcotics and stimulants have the potential for abuse. Yet, e-prescribing was unavailable until the Drug Enforcement Administration legalized it in 2010. Since then, electronic prescriptions have grown dramatically, according to 18 months of transactional data recently released in a study co-authored by the Office of the National Coordinator for Health IT’s Office of Planning, Evaluation, and Analysis.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access